Epidermal growth factor receptor as a biomarker for cervical cancer
Links shared publicly online about this topic.
- 52total visits
Epidermal growth factor receptor as a biomarker for cervical cancer
View full resource at annonc.oxfordjournals.org
Tags: HPV, Cancer, Cervical Cancer
Most Recently Shared on August 23, 2011 at 11:57 am By:
RT @Annals_Oncology: Free review: Epidermal growth factor receptor as a biomarker for cervical cancer http://t.co/HBmtr4v #cancer
Qiagen Gains Approval in Japan for EGFR Companion Diagnostic, Rights to Cancer Biomarkers | IVD Technology
ivdtechnology.com — “Qiagen announced the regulatory approval of its therascreen EGFR Mutation Detection Kit RGQ in Japan. EGFR, the epidermal growth factor receptor, has been shown to play an important role in certain cancers and is the target of many new anticancer drugs. The approval is a milestone in Qiagen's Personalized Healthcare strategy, as Japan is one of the world's largest markets for companion diagnostic tests.” View full resource at ivdtechnology.com
Most Recently Shared on January 10, 2012 at 6:56 pm By:
IVD Technology Health Magazine
Qiagen Gains Approval in Japan for EGFR Companion Diagnostic, Rights to Cancer Biomarkers http://t.co/L0pEGjEk
Qiagen Receives Regulatory Approval in Japan for EGFR Companion Diagnostic to Guide Cancer Treatments | Biomarker Commons
biomarkercommons.org — “Qiagen today announced the regulatory approval of its therascreen EGFR Mutation Detection Kit RGQ in Japan. EGFR, the epidermal growth factor receptor, has been shown to play an important role in certain cancers and is the target of many new anticancer drugs.” View full resource at biomarkercommons.org
Most Recently Shared on January 10, 2012 at 12:53 pm By:
Oncology Article | Cervical Cancer
mdlinx.com — “Membranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor Predicts Outcome after Chemoradiotherapy of Lymph Node-Negative Cervical Cancer” View full resource at mdlinx.com
Most Recently Shared on August 11, 2011 at 11:22 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Membranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor Predicts Outcome ... http://bit.ly/peYvtr #oncology
Oncology Article | Neoplasms
mdlinx.com — “Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer” View full resource at mdlinx.com
Most Recently Shared on February 8, 2011 at 1:23 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical canc... http://bit.ly/e4Jl7X #oncology
Access : Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer : Modern Pathology
nature.com — “Modern Pathology features diagnostic anatomic pathology and contains original scientific papers, selected short courses, appropriate special lectures, reviews, editorials, letters to the editor, and Academy News. In many ways, it reflects the instructive and informative composition of the Academy's annual meeting. Publication is monthly.” View full resource at nature.com
Most Recently Shared on January 22, 2011 at 6:08 pm By:
Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer: Author... http://bit.ly/ehecOi
Oncology Medical News about Colorectal Neoplasms
mdlinx.com — “New Strategies in Colorectal Cancer: Biomarkers of Response to Epidermal Growth Factor Receptor Monoclonal Antibodies and Potential Therapeutic Targets in PI3K and MAPK Pathways” View full resource at mdlinx.com
Most Recently Shared on July 7, 2010 at 10:16 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
New Strategies in Colorectal Cancer: Biomarkers of Response to Epidermal Growth Factor Receptor Monoclona... http://bit.ly/aNgHTe #oncology
New biomarkers can predict patients' response to certain drugs
news-medical.net — “Recent advances in cancer therapeutics have led to the discovery of biomarkers that can predict patient response to certain drugs. Screening for mutations in the epidermal growth factor receptor (EGRF) prior to non-small cell lung cancer treatment, for example, has been shown to indentify patients who are likely to respond to treatment with erlontinib. This maximizes the drug's impact, and spares patients who are not likely to benefit from being subjected to potentially debilitating side effects” View full resource at news-medical.net
Most Recently Shared on November 21, 2009 at 4:08 am By:
Ovarian Cancer News: New biomarkers can predict patients' response to certain drugs: Recent.. http://buzzup.com/ik0q
Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor-Targeted Therapy in Metastatic Colorectal Cancer -- Siena et al., 10.1093/jnci/djp280 -- JNCI Journal of the National Cancer Institute
jnci.oxfordjournals.org — “Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor-Targeted Therapy in Metastatic Colorectal Cancer -- Siena et al., 10.1093/jnci/djp280 -- JNCI Journal of the National Cancer Institute” View full resource at jnci.oxfordjournals.org
Most Recently Shared on September 9, 2009 at 5:32 pm By:
J Nat'l Cancer Inst Oncology and Medical Journal
Open Access:Overview of cellular signaling pathways involved in the proliferation and progression of colorectal cancer http://bit.ly/15hOez
Advertisement
